Robert DeSantis - 21 Apr 2023 Form 4 Insider Report for INTUITIVE SURGICAL INC (ISRG)

Role: EVP & Chief Product Officer
Signature: By: Donna Spinola For: DeSantis, Robert
Issuer symbol: ISRG
Transactions as of: 21 Apr 2023
Net transactions value: -$1,161,212
Form type: 4
Filing time: 24 Apr 2023, 18:10:17 UTC
Previous filing: 01 Mar 2023
Next filing: 12 May 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ISRG	Common Stock	Options Exercise	$536,390	+2,184	+23%	$245.60	11,612	21 Apr 2023	Direct	F1
transaction	ISRG	Common Stock	Sale	$650,653	-2,184	-19%	$297.92	9,428	21 Apr 2023	Direct	F1, F2
transaction	ISRG	Common Stock	Options Exercise	$263,178	+1,086	+12%	$242.34	10,514	21 Apr 2023	Direct	F1
transaction	ISRG	Common Stock	Sale	$323,539	-1,086	-10%	$297.92	9,428	21 Apr 2023	Direct	F1, F2
transaction	ISRG	Common Stock	Options Exercise	$49,058	+273	+2.9%	$179.70	9,701	21 Apr 2023	Direct	F1
transaction	ISRG	Common Stock	Sale	$81,354	-273	-2.8%	$298.00	9,428	21 Apr 2023	Direct	F1, F3
transaction	ISRG	Common Stock	Options Exercise	$48,590	+273	+2.9%	$177.99	9,701	21 Apr 2023	Direct	F1
transaction	ISRG	Common Stock	Sale	$81,354	-273	-2.8%	$298.00	9,428	21 Apr 2023	Direct	F1, F3
transaction	ISRG	Common Stock	Options Exercise	$510,552	+2,444	+26%	$208.90	11,872	21 Apr 2023	Direct	F1
transaction	ISRG	Common Stock	Sale	$728,134	-2,444	-21%	$297.93	9,428	21 Apr 2023	Direct	F1, F4
transaction	ISRG	Common Stock	Sale	$356,302	-1,196	-13%	$297.91	8,232	21 Apr 2023	Direct	F1, F5
transaction	ISRG	Common Stock	Sale	$347,645	-1,167	-14%	$297.90	7,065	21 Apr 2023	Direct	F1, F6

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ISRG	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-273	-22%	$0.000000	996	21 Apr 2023	Common Stock	273	$177.99	Direct	F1, F7
transaction	ISRG	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-273	-19%	$0.000000	1,176	21 Apr 2023	Common Stock	273	$179.70	Direct	F1, F8
transaction	ISRG	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-2,444	-27%	$0.000000	6,579	21 Apr 2023	Common Stock	2,444	$208.90	Direct	F1, F9
transaction	ISRG	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-1,086	-52%	$0.000000	996	21 Apr 2023	Common Stock	1,086	$242.34	Direct	F1, F9
transaction	ISRG	Non-Qualified Stock Option (right to buy)	Options Exercise	$0	-2,184	-32%	$0.000000	4,566	21 Apr 2023	Common Stock	2,184	$245.60	Direct	F1, F7

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on November 21, 2023.
F2	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.55 to $299.16 as follows: 656 shares sold at $296.55 to $297.55; 1.979 shares sold at $297.56 to $298.53; and 635 shares sold at $298.62 to $299.16. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F3	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.61 to $299.31 as follows: 116 shares sold at $296.61 to $297.00; 370 shares sold at $297.78 to $298.74; and 60 shares sold at $298.99 to $299.31. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F4	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.52 to $299.30 as follows: 612 shares sold at $296.52 to $297.52; 1.413 shares sold at $297.57 to $298.50; and 419 shares sold at $298.63 to $299.30. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F5	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.59 to $299.27 as follows: 271 shares sold at $296.59 to $297.41; 725 shares sold at $297.66 to $298.62; and 200 shares sold at $298.68 to $299.27. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F6	The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $296.39 to $299.22 as follows: 216 shares sold at $296.39 to $297.12; 705 shares sold at $297.42 to $298.41; and 246 shares sold at $298.50 to $299.22. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
F7	Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
F8	Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time.
F9	Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.